Roche Holding AG
RHHVF
$466.28
-$0.41-0.09%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.65% | 7.86% | 13.65% | 0.83% | 6.79% |
| Total Other Revenue | 3.61% | 1.91% | 9.26% | -3.06% | 12.64% |
| Total Revenue | 9.46% | 7.67% | 13.52% | 0.71% | 6.96% |
| Cost of Revenue | 11.97% | 10.14% | 13.69% | 0.86% | 4.71% |
| Gross Profit | 8.58% | 6.80% | 13.47% | 0.67% | 7.78% |
| SG&A Expenses | 9.36% | 7.57% | 11.83% | -0.78% | 5.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -62.96% | -63.57% | 47.22% | 53.17% | -47.83% |
| Total Operating Expenses | 6.02% | 4.29% | 12.00% | -0.64% | 1.70% |
| Operating Income | 18.43% | 16.50% | 16.31% | 3.19% | 23.64% |
| Income Before Tax | 127.39% | 123.67% | 27.82% | 13.40% | -26.61% |
| Income Tax Expenses | 44.32% | 41.96% | 26.15% | 11.92% | 889.97% |
| Earnings from Continuing Operations | 163.42% | 159.11% | 28.20% | 13.74% | -47.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.99% | -14.09% | -5.38% | 6.51% | -9.43% |
| Net Income | 197.81% | 192.94% | 29.80% | 15.16% | -53.32% |
| EBIT | 18.43% | 16.50% | 16.31% | 3.19% | 23.64% |
| EBITDA | 16.44% | 14.53% | 15.95% | 2.87% | 20.25% |
| EPS Basic | 198.19% | 193.31% | 29.97% | 15.31% | -53.20% |
| Normalized Basic EPS | 18.70% | 16.75% | 19.18% | 5.74% | 23.48% |
| EPS Diluted | 198.24% | 193.35% | 29.72% | 15.09% | -53.48% |
| Normalized Diluted EPS | 18.40% | 16.46% | 18.88% | 5.47% | 23.48% |
| Average Basic Shares Outstanding | -0.13% | -0.13% | -0.13% | -0.13% | -0.25% |
| Average Diluted Shares Outstanding | 0.12% | 0.12% | 0.12% | 0.12% | -0.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.15% | -0.15% | -- |